Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings
Authors
Keywords
-
Journal
BMC Pulmonary Medicine
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-03
DOI
10.1186/s12890-022-02257-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pandemic-related declines in hospitalization for non-COVID-19-related illness in the United States from January through July 2020
- (2022) Jennifer L. Nguyen et al. PLoS One
- Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study
- (2022) Yen Chung et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Amikacin Liposome Inhalation Suspension for Refractory MAC Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-Term Exposure
- (2021) David E. Griffith et al. CHEST
- Diagnostic Accuracy of Health Care Administrative Diagnosis Codes to Identify Nontuberculous Mycobacteria Disease: A Systematic Review
- (2021) Carlos Mejia-Chew et al. Open Forum Infectious Diseases
- REFRACTORY NONTUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE: DESCRIPTIVE ANALYSIS FROM THE UNITED STATES BRONCHIECTASIS AND NTM RESEARCH REGISTRY
- (2021) TIMOTHY AKSAMIT et al. CHEST
- Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments
- (2021) Jakko van Ingen et al. Expert Review of Respiratory Medicine
- Virtually Perfect? Telemedicine for Covid-19
- (2020) Judd E. Hollander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
- (2020) Charles L. Daley et al. EUROPEAN RESPIRATORY JOURNAL
- Trends in Emergency Department Visits and Hospital Admissions in Health Care Systems in 5 States in the First Months of the COVID-19 Pandemic in the US
- (2020) Molly M. Jeffery et al. JAMA Internal Medicine
- Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis
- (2020) Shunsuke Uno et al. BMC Pulmonary Medicine
- Guidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung disease
- (2019) Theodore K. Marras et al. JOURNAL OF MEDICAL ECONOMICS
- Evaluating differences in tuberculosis and nontuberculous mycobacterial lung disease in Florida
- (2019) Emily Klann et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease
- (2018) Byung Woo Jhun et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- High mortality in patients with Mycobacterium avium complex lung disease: a systematic review
- (2018) Roland Diel et al. BMC INFECTIOUS DISEASES
- Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease
- (2018) Roland Diel et al. CHEST
- Sensitivity of Claims-Based Algorithms to Ascertain Smoking Status More Than Doubled with Meaningful Use
- (2018) Jinhai Huo et al. VALUE IN HEALTH
- Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT): A Prospective, Open-Label, Randomized Study
- (2018) David E Griffith et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The cost of Mycobacterium avium complex lung disease in Canada, France, Germany, and the United Kingdom: a nationally representative observational study
- (2018) S. M. Goring et al. BMC HEALTH SERVICES RESEARCH
- Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population
- (2018) Theodore K. Marras et al. RESPIRATORY MEDICINE
- Burden of non-tuberculous mycobacterial pulmonary disease in Germany
- (2017) Roland Diel et al. EUROPEAN RESPIRATORY JOURNAL
- Lung Function Decline According to Clinical Course in Nontuberculous Mycobacterial Lung Disease
- (2016) Hye Yun Park et al. CHEST
- Self controlled case series methods: an alternative to standard epidemiological study designs
- (2016) Irene Petersen et al. BMJ-British Medical Journal
- Self controlled case series methods: an alternative to standard epidemiological study designs
- (2016) Irene Petersen et al. BMJ-British Medical Journal
- Risk Factors for Recurrence after Successful Treatment of Mycobacterium avium Complex Lung Disease
- (2015) Bo Young Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria
- (2015) D. Rebecca Prevots et al. CLINICS IN CHEST MEDICINE
- Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare Beneficiaries
- (2012) Jennifer Adjemian et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease
- (2011) Mauli Mehta et al. RESPIRATORY MEDICINE
- Nontuberculous Mycobacterial Disease Prevalence and Risk Factors: A Changing Epidemiology
- (2009) P. Maureen Cassidy et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More